Summary
3-FA is a potent stimulant with mild entactogenic properties. It releases dopamine at levels significantly higher than amphetamine at equivalent doses but lacks the productivity-enhancing effects of 2-FA or 2-FMA. The substance has an extremely limited research history and unknown long-term toxicity profile. Risk of neurotoxicity, cardiovascular strain, and compulsive redosing. Not recommended for individuals with cardiovascular conditions or psychiatric disorders.
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 20-30mg | 30-50mg | 50-70mg | 70mg+ |
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects | Total |
|---|---|---|---|---|---|---|
| Oral | 20-60 min | 30-60 min | 2-4 hrs | 2-4 hrs | 1-12 hrs | 240-0 min |
| Insufflated | 1-10 min | 10-30 min | 1.5-3 hrs | 1-2 hrs | 1-12 hrs | 240-0 min |
Tolerance
Build-up
develops over days to weeks of regular use
Reset
3โ7 days for acute; 1โ3 weeks for full reset
Cross-tolerance
Effects
Positive
- Stimulation
- Physical euphoria
- Increased energy/alertness
Negative
- Increased heart rate
- Increased perspiration
- Teeth grinding
- Insomnia
- Weight loss
- Sweating
- Bruxism
- Decreased need for sleep
- Decreased appetite
- Disturbed sleep patterns
- Itchiness
Positive
- Cognitive euphoria
- Enhanced sociability
- Motivation enhancement
- Focus enhancement
- Analysis enhancement
- Wakefulness
- Anxiety suppression
- Euphoria
- Increased sociability
- Mood lift
Negative
- Compulsive redosing
- Aggressiveness
- Depression
- Anxiety
- Irritability
- Thought deceleration
- Cognitive fatigue
- Motivation depression
- Thought acceleration
- Time distortion
- Excessive talking
- Moodiness
- Focus intensification
Positive
- Tactile enhancement
- Increased music appreciation
- Increased libido
- Pattern recognition enhancement
Negative
- Appetite suppression
- Dehydration
- Increased sexuality
- Visual and auditory hallucinations
- Tactile intensification
- Drifting